<code id='83F724CA9A'></code><style id='83F724CA9A'></style>
    • <acronym id='83F724CA9A'></acronym>
      <center id='83F724CA9A'><center id='83F724CA9A'><tfoot id='83F724CA9A'></tfoot></center><abbr id='83F724CA9A'><dir id='83F724CA9A'><tfoot id='83F724CA9A'></tfoot><noframes id='83F724CA9A'>

    • <optgroup id='83F724CA9A'><strike id='83F724CA9A'><sup id='83F724CA9A'></sup></strike><code id='83F724CA9A'></code></optgroup>
        1. <b id='83F724CA9A'><label id='83F724CA9A'><select id='83F724CA9A'><dt id='83F724CA9A'><span id='83F724CA9A'></span></dt></select></label></b><u id='83F724CA9A'></u>
          <i id='83F724CA9A'><strike id='83F724CA9A'><tt id='83F724CA9A'><pre id='83F724CA9A'></pre></tt></strike></i>

          00:00
          00:00 00:00 LIVE
          buffering
          Replay
          LIVE
          00:00 / 00:00
          LIVE
          CC
          Opacity :
          Share:
          Close

          leisure time

          author:leisure time    - browse:8949
          Alexis Borisy
          Venture capitalist Alexis Borisy Vanessa Leroy for STAT

          EQRx is done, sold for its cash.

          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

          advertisement

          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          hotspot